Agomab Therapeutics NV

AGMB·NASDAQ·$11.05·$544M

Financials

20-FAnnual report (foreign)04/23/26

Disclosures

6-KForeign issuer report10/13/266-KForeign issuer report10/01/266-KForeign issuer report09/14/266-KForeign issuer report09/11/266-KForeign issuer report08/10/26

Prospectuses and Registrations

S-8Registration of securities for employees03/11/26424B4Prospectus02/06/26F-1/ARegistration (foreign issuer, amended)01/29/26F-1Registration (foreign issuer)01/16/26

Proxies

No matching filings.

Ownership

Form 4Insider transaction10/22/26Form 4Insider transaction10/09/26Form 4Insider transaction10/07/26Form 4Insider transaction10/07/26Form 4Insider transaction10/07/26

Other

CERTCEO/CFO certification02/05/268-A12B8-A12B02/03/26EFFECTRequest for effectiveness01/30/26DRS/ADRS/A12/17/25DRS/ADRS/A10/28/25